Azora Therapeutics, Inc. (AZR)
NASDAQ: AZR · Real-Time Price · USD
3.850
-0.020 (-0.52%)
At close: Nov 20, 2026, 4:00 PM EST
3.770
-0.080 (-2.08%)
After-hours: Nov 20, 2026, 6:33 PM EST
Azora Therapeutics Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Azora Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $10.67. The average 1-year stock price forecast is 177.14% higher than the current stock price, while the lowest is $6.00 (+55.84%) and the highest is $14 (+263.64%).
Price Target: $10.67 (+177.14%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Azora Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Maintains $14 | Buy | Maintains | $14 | +263.64% | Nov 20, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $12 | Buy | Maintains | $12 | +211.69% | Nov 17, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 2, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Initiates $11 | Buy | Initiates | $11 | +185.71% | Aug 3, 2026 |
| Lucid Capital | Lucid Capital | Buy Initiates $6 | Buy | Initiates | $6 | +55.84% | Jun 15, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
-14.42